BiotechTube
Macromoltek

Macromoltek

Austin, United States· Est.
macromoltek.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Macromoltek is a private, Austin-based biotech firm founded in 2010, operating as a computational antibody design platform and services provider. The company leverages proprietary AI algorithms and advanced computational modeling to predict, optimize, and engineer antibody structures for its partners, streamlining the early-stage drug discovery pipeline. It primarily serves biotech and pharmaceutical companies through collaborative partnerships, offering custom antibody engineering from target identification to lead optimization. The company is led by its co-founders, CEO Monica Berrondo, PhD, and CTO Susana Kaufmann, who bring deep expertise in computational biology and software engineering.

AntibodiesAI / Machine LearningProteomics

Technology Platform

Integrated AI and computational modeling platform for antibody discovery, structure prediction, epitope mapping, and developability assessment.

Opportunities

The global antibody therapeutics market is large and growing, creating strong demand for technologies that accelerate and de-risk discovery.
The increasing complexity of next-generation antibody formats (bispecifics, ADCs) is ideally suited for computational design.
Partnerships with both large pharma and agile biotechs provide diverse revenue streams.

Risk Factors

The company's value proposition depends on the clinical validation of its AI-designed antibodies, which is not yet fully proven.
It operates in a highly competitive landscape with other AI-biotech startups and internal pharma efforts.
Its service-based model may limit revenue upside compared to owning therapeutic assets.

Competitive Landscape

Macromoltek competes in the computational antibody design space with other AI-driven biotechs like Absci, BigHat Biosciences, and LabGenius, as well as with software companies such as Schrödinger. It also competes indirectly with large pharmaceutical companies' internal computational teams and traditional CROs offering antibody discovery services.

More companies in AI / Machine Learning →More companies in United States →